Gamida Cell Stock Price

Gamida Cell Stock Price. The company's shares closed last wednesday at. Their forecasts range from $11.00 to $22.00.

Gamida Cell (NASDAQ GMDA) is up 82 after Presenting Results from fdgtacademy.com

With gamida cell ltd stock trading at $2.72 per share, the total value of gamida cell ltd stock (market capitalization) is $201.62m. Gamida cell ltd (gmda) 3.24 +0.28 ( +9.46% ) usd | nasdaq | jan 21, 16:00 A look at the stock’s price movement, the close in the last trading session was $2.53, moving within a range at $2.52 and

Gamida cell ltd (gmda) 3.24 +0.28 ( +9.46% ) usd | nasdaq | jan 21, 16:00 Get the latest gamida cell ltd. As of 2022 january 13, thursday current price of gmda stock is 2.330$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).

Gamida cell ltd's share price could reach $13.67 by nov 16, 2022. The stock went to a low of $2.90 during the session. Private updated jan 22, 2022 12:59 am.

Gamida cell ltd stock was originally listed at a price of $8.44 in oct 26, 2018. Jmp securities thinks gamida cell’s stock is going to recover.

(nasdaq:gmda) price on friday, december 31, rose 0.40% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.54. Gamida cell stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period.

On average, wall street analysts predict that. Gamida cell ltd's share price could reach $13.67 by nov 16, 2022.

Their forecasts range from $11.00 to $22.00. On average, they anticipate gamida cell's share price to reach $14.60 in the next twelve months.

(nasdaq:gmda) price on friday, december 31, rose 0.40% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.54. Gamida cell ltd's share price could reach $13.67 by nov 16, 2022.

The company's shares closed last wednesday at. On average, wall street analysts predict that.

Stock analysis for gamida cell ltd (gmda:nasdaq gm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. (nasdaq:gmda) price on friday, december 31, rose 0.40% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.54.

This suggests a possible upside of 393.2% from the stock's current price. Jmp securities thinks gamida cell’s stock is going to recover.

On average, wall street analysts predict that. Jmp securities thinks gamida cell’s stock is going to recover.

Gamida Cell Stock Price Has Been Showing A Declining Tendency So We Believe That Similar Market Segments Were Not Very Popular In The Given Period.

Their forecasts range from $11.00 to $22.00. Gamida cell announces pricing of $35 million public offering of ordinary shares read more (nasdaq:gmda) price on friday, december 31, rose 0.40% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.54.

Private Updated Jan 22, 2022 12:59 Am.

(gmda) stock rallied over 9.46% intraday to trade at $3.24 a share on nasdaq. A look at the stock’s price movement, the close in the last trading session was $2.53, moving within a range at $2.52 and Jmp securities thinks gamida cell’s stock is going to recover.

Summary Of All Time Highs, Changes And Price Drops For Gamida Cell;

Get the latest gamida cell ltd. With gamida cell ltd stock trading at $2.72 per share, the total value of gamida cell ltd stock (market capitalization) is $201.62m. About the gamida cell ltd.

This Suggests A Possible Upside Of 393.2% From The Stock's Current Price.

— stock price and discussion | stocktwits. Gamida cell ltd stock was originally listed at a price of $8.44 in oct 26, 2018. The average gamida cell ltd stock price prediction forecasts a potential upside of 502.07% from the current gmda share price of $2.27.

Gamida Cell Ltd's Share Price Could Reach $13.67 By Nov 16, 2022.

The stock went to a low of $2.90 during the session. Gmda), an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases, today announced the pricing of an underwritten public offering of 13,333,334 ordinary shares at a public offering price of $4.50 per share for aggregate gross proceeds of approximately $60 million,. On average, wall street analysts predict that.